AU2002238541A1 - Invasomes for the treatment of disease states, production and use thereof - Google Patents

Invasomes for the treatment of disease states, production and use thereof

Info

Publication number
AU2002238541A1
AU2002238541A1 AU2002238541A AU2002238541A AU2002238541A1 AU 2002238541 A1 AU2002238541 A1 AU 2002238541A1 AU 2002238541 A AU2002238541 A AU 2002238541A AU 2002238541 A AU2002238541 A AU 2002238541A AU 2002238541 A1 AU2002238541 A1 AU 2002238541A1
Authority
AU
Australia
Prior art keywords
invasomes
treatment
production
disease states
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002238541A
Inventor
Alfred Fahr
Rolf Muller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vectron Therapeutics AG
Original Assignee
Vectron Therapeutics AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vectron Therapeutics AG filed Critical Vectron Therapeutics AG
Publication of AU2002238541A1 publication Critical patent/AU2002238541A1/en
Abandoned legal-status Critical Current

Links

AU2002238541A 2001-02-08 2002-02-08 Invasomes for the treatment of disease states, production and use thereof Abandoned AU2002238541A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10105659.1 2001-02-08

Publications (1)

Publication Number Publication Date
AU2002238541A1 true AU2002238541A1 (en) 2002-08-19

Family

ID=

Similar Documents

Publication Publication Date Title
AP2004003002A0 (en) azabicyclic-substituted fused-heteroaryl compoundsfor the treatment of disease.
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
AU2002255248A1 (en) Diagnosis, treatment and research of mental disorders
AU2003219690A1 (en) Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease
HK1098737A1 (en) Process for the preparation of 1,1,1,3,3-pentafluoro-2-chloropropene and 1,1,1,3,3,3-hexafluoro-2-chloropropane
AU2002303502A1 (en) Improved leads for the treatment of patients with chf
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
AU2002312897A1 (en) Drugs for the treatment of the alzheimer disease
AU2003293589A1 (en) Heavy ceramic moulded body, method for producing said body and use of the same
AU2002319286A1 (en) Skin treatment
AU2003303217A1 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
AU2003266965A1 (en) Use of carboxamides for the treatment of tinnitus
AU2002246049A1 (en) Water-absorbing agent, method for the production thereof and use of the same
HUP0401577A3 (en) Process for the preparation of 2,4-didezoxyhexoses and 2,4,6-tridezoxyhexoses
AU2001277737A1 (en) Novel substance having physiological activity, process for producing the same, and use
AU2002327440A1 (en) Treatment of type i diabetes
AU2002348998A1 (en) N-methyl-homocystines, use thereof and method for the production thereof
AU2002238541A1 (en) Invasomes for the treatment of disease states, production and use thereof
AU2002256967A1 (en) Treating or reducing the risk of cardiovascular disease
HK1061655A1 (en) Caloporoside derivatives, methods for the production thereof and their use
GB0128628D0 (en) Disease treatment
AU3582101A (en) The treatment of functional gastrointestinal disorders
AU2002365654A1 (en) Treatment of diseases via the skin
AU2002368208A1 (en) Use of 2,3 alkylcarbonyloxybenzoic acids in the treatment of anthrax
AU2002322806A1 (en) Metformin in the treatment of hyperglycemic conditions